| Stanford University | Dr. Michael P Snyder PhD | Dissecting cell-specific genetic and molecular drivers of amyotrophic lateral sclerosis for therapeutic insights |
$12,999,837 |
| Stanford University | Sergiu P Pasca | Transplantation of human forebrain assembloids as a platform for therapeutic screening in neurodevelopmental disorders |
$13,999,999 |
| University of California, Los Angeles | Daniel Geschwind | Advancing Therapeutic Discovery Through Multimodal Analyses of Genetic and Cellular Mechanisms in Neuropsychiatric Disorders |
$13,957,175 |
| University of California, San Diego | Dr. Gene Wei-Ming Yeo | Reversing age-dependent neurodegeneration by elimination of RNA pollution |
$13,000,000 |
| Salk Institute for Biological Studies | Christian Metallo | Tracing the metabolic basis of neurological disorders |
$12,995,613 |
| University of California, San Francisco | Dr. Arnold Kriegstein | Defining the Developmental Origins and Neuronal Regulation of Glioblastoma Stem Cells |
$13,578,858 |
| University of California, San Diego | Jonathan Sebat | Modeling the genetic basis of psychopathology in schizophrenia and autism |
$12,703,708 |
| University of California, San Francisco | Mercedes Paredes | Multi-gene modulation to rescue CNS-associated microdeletion syndromes |
$6,253,897 |
| University of California, Los Angeles | Aparna Bhaduri | Defining Neurovascular Metabolism in Neurodevelopmental and Neuropsychiatric Disorders |
$10,330,000 |
| University of California, San Francisco | Tomasz Nowakowski | CIRM Center for Neuropsychiatric Stem Cell Proteomics |
$13,781,522 |
| Scripps Research Institute | Xin Jin | Translational epigenomics: dissecting cell type-specific function of neuropsychiatric risk genes in vivo |
$11,376,314 |
| Scripps Research Institute | Stuart A Lipton | Multiomic Studies of Idiopathic Intellectual Disability and Autism Spectrum Disorder (ID/ASD) |
$17,365,387 |
| University of California, San Francisco | Alex Pollen | Deep phenotyping of human brain organoid models of autism spectrum disorder to unravel disease heterogeneity and develop biomarkers and treatments |
$12,297,272 |
